Hanmi Science Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hanmi Science Company Limited with three other
companies in this sector in South Korea:
Jeil Pharma Holdings Inc
sales of 617.28 billion Korean Won [US$546.91 million]
of which 100%
was Product sales),
Dong-A Socio Holdings Co Ltd
(726.17 billion Korean Won [US$643.38 million]
of which 67%
was Pharmaceutication), and
Dong A St Co Ltd
(560.54 billion Korean Won [US$496.63 million]
Hanmi Science Company Limited reported sales of 665.28 billion Korean Won (US$589.44 million)
December of 2016.
decrease of 14.3%
versus 2015, when the company's sales were 776.22 billion Korean Won.
Contributing to the drop in overall sales was the 84.6% decline
in Mainstay Industry, from 173.32 billion Korean Won to 26.66 billion Korean Won.
However, these declines were partially offset by the increase in sales of
Pharmaceutical Sales (up 5.9% to 635.77 billion Korean Won)
Others (up 4.3% to 2.85 billion Korean Won)